Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Trinity Biotech ( (TRIB) ) has provided an update.
Trinity Biotech and its subsidiaries have entered into a third amended and restated credit agreement with Perceptive Credit Holdings III, LP. This agreement involves multiple borrowers and guarantors, aiming to streamline financial operations and potentially enhance liquidity and financial management for the company.
More about Trinity Biotech
YTD Price Performance: -61.36%
Average Trading Volume: 175,839
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $14.94M
For detailed information about TRIB stock, go to TipRanks’ Stock Analysis page.